| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 11.252 | 4.022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Total Income - EUR | 11.252 | 4.022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Total Expenses - EUR | 4.322 | 1.942 | 428 | 283 | 0 | 0 | 0 | 0 | 0 | - |
| Gross Profit/Loss - EUR | 6.930 | 2.080 | -428 | -283 | 0 | 0 | 0 | 0 | 0 | - |
| Net Profit/Loss - EUR | 6.593 | 1.959 | -428 | -283 | 0 | 0 | 0 | 0 | 0 | - |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
Check the financial reports for the company - Samaneh Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.008 | 646 | 289 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Current Assets | 15.005 | 17.496 | 16.681 | 16.375 | 16.057 | 15.753 | 15.404 | 15.451 | 15.405 | - |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Receivables | 183 | 545 | 146 | 144 | 141 | 138 | 135 | 135 | 7.318 | - |
| Cash | 14.822 | 16.951 | 16.534 | 16.231 | 15.917 | 15.615 | 15.269 | 15.316 | 8.087 | - |
| Shareholders Funds | 14.844 | 16.652 | 15.942 | 15.366 | 15.068 | 14.783 | 14.455 | 14.500 | 14.456 | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | 1.169 | 1.490 | 1.028 | 1.009 | 989 | 970 | 949 | 952 | 949 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Samaneh Med Srl